A screen for novel hepatitis C virus RdRp inhibitor identifies a broad-spectrum antiviral compound

Hepatitis C virus (HCV) is a global pathogen and infects more than 185 million individuals worldwide. Although recent development of direct acting antivirals (DAA) has shown promise in HCV therapy, there is an urgent need for the development of more affordable treatment options. We initiated this st...

Descripción completa

Detalles Bibliográficos
Autores principales: Madhvi, Abhilasha, Hingane, Smita, Srivastav, Rajpal, Joshi, Nishant, Subramani, Chandru, Muthumohan, Rajagopalan, Khasa, Renu, Varshney, Shweta, Kalia, Manjula, Vrati, Sudhanshu, Surjit, Milan, Ranjith-Kumar, C. T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517564/
https://www.ncbi.nlm.nih.gov/pubmed/28725041
http://dx.doi.org/10.1038/s41598-017-04449-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5517564/
https://www.ncbi.nlm.nih.gov/pubmed/28725041
http://dx.doi.org/10.1038/s41598-017-04449-3

Ejemplares similares